Filing Details

Accession Number:
0001225208-15-010720
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-30 16:56:10
Reporting Period:
2015-04-28
Filing Date:
2015-04-30
Accepted Time:
2015-04-30 16:56:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559387 Paulus Stoffels One Johnson & Johnson Plaza
New Brunswick NJ 08933
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-28 160,133 $65.37 213,173 No 4 M Direct
Common Stock Acquisiton 2015-04-28 24,920 $62.20 238,093 No 4 M Direct
Common Stock Acquisiton 2015-04-28 24,521 $62.62 262,614 No 4 M Direct
Common Stock Acquisiton 2015-04-28 19,109 $61.75 281,723 No 4 M Direct
Common Stock Disposition 2015-04-28 187,250 $100.73 94,473 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (Right to Buy) Disposition 2015-04-28 24,920 $0.00 24,920 $62.20
Common Stock Employee Stock Options (Right to Buy) Disposition 2015-04-28 160,133 $0.00 160,133 $65.37
Common Stock Employee Stock Options (Right to Buy) Disposition 2015-04-28 24,521 $0.00 24,521 $62.62
Common Stock Employee Stock Options (Right to Buy) Disposition 2015-04-28 19,109 $0.00 19,109 $61.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-01-11 2021-01-08 No 4 M Direct
0 2015-01-18 2022-01-14 No 4 M Direct
0 2013-02-09 2020-02-07 No 4 M Direct
0 2011-02-12 2018-02-10 No 4 M Direct
Footnotes
  1. Shares sold to cover exercise price and taxes owed upon exercise of option.
  2. This transaction was executed in multiple trades at prices ranging from $100.63 to $100.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.